← Back to Search

Mindfulness-Based Attention Training for Teams (MBAT-T) for Cognitive Impairment

N/A
Waitlist Available
Led By Amishi P Jha, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (testing session 1) to week 5 (testing session 2)
Awards & highlights

Study Summary

This trial will study how a mindfulness course may help people think, feel, and act differently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (testing session 1) to week 5 (testing session 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (testing session 1) to week 5 (testing session 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Attentional Performance
Change in Working Memory Performance
Secondary outcome measures
Change in Cohesion
Change in Decentering
Change in Mindfulness
+7 more
Other outcome measures
Change in Accuracy on Cognitive and Marksmanship Drills
Change in Reaction Time on Cognitive and Marksmanship Drills

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Based Attention Training for Teams (MBAT-T)Experimental Treatment1 Intervention
Teams randomized to this group will receive 4, 2-2.5-hour sessions delivered over 4 weeks of mindfulness training and 15 minutes of daily, out-of-class mindfulness exercises, that will be delivered and tracked using a measuring mindfulness application.
Group II: Mindfulness-Based Attention Training for Individuals (MBAT-I)Active Control1 Intervention
Individuals randomized to this group will receive 4, 2-2.5-hour sessions delivered over 4 weeks of mindfulness training and 15 minutes of daily, out-of-class mindfulness exercises, that will be delivered and tracked using a measuring mindfulness application.
Group III: No-trainingActive Control1 Intervention
Teams will not engage in any mindfulness training
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MBAT-T
2021
N/A
~360

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
902 Previous Clinical Trials
409,660 Total Patients Enrolled
United States Department of DefenseFED
865 Previous Clinical Trials
327,343 Total Patients Enrolled
Amishi P Jha, PhDPrincipal InvestigatorUniversity of Miami

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~91 spots leftby Apr 2025